166 related articles for article (PubMed ID: 34020765)
21. Reagents for Mass Cytometry.
Arnett LP; Rana R; Chung WW; Li X; Abtahi M; Majonis D; Bassan J; Nitz M; Winnik MA
Chem Rev; 2023 Feb; 123(3):1166-1205. PubMed ID: 36696538
[TBL] [Abstract][Full Text] [Related]
22. MIBI-TOF: A multiplexed imaging platform relates cellular phenotypes and tissue structure.
Keren L; Bosse M; Thompson S; Risom T; Vijayaragavan K; McCaffrey E; Marquez D; Angoshtari R; Greenwald NF; Fienberg H; Wang J; Kambham N; Kirkwood D; Nolan G; Montine TJ; Galli SJ; West R; Bendall SC; Angelo M
Sci Adv; 2019 Oct; 5(10):eaax5851. PubMed ID: 31633026
[TBL] [Abstract][Full Text] [Related]
23. Research Techniques Made Simple: Use of Imaging Mass Cytometry for Dermatological Research and Clinical Applications.
Veenstra J; Dimitrion P; Yao Y; Zhou L; Ozog D; Mi QS
J Invest Dermatol; 2021 Apr; 141(4):705-712.e1. PubMed ID: 33752807
[TBL] [Abstract][Full Text] [Related]
24. Isotopically Encoded Nanotags for Multiplexed Ion Beam Imaging.
Harmsen S; Coskun AF; Ganesh S; Nolan GP; Gambhir SS
Adv Mater Technol; 2020 Jul; 5(7):. PubMed ID: 32661501
[TBL] [Abstract][Full Text] [Related]
25. Immunophenotyping by Mass Cytometry.
Behbehani GK
Methods Mol Biol; 2019; 2032():31-51. PubMed ID: 31522411
[TBL] [Abstract][Full Text] [Related]
26. Coupling imaging mass cytometry with Alcian blue histochemical staining for a single-slide approach.
Hemon P; Ben-Guigui D; Geier M; Castillon M; Paranthoen C; Pers JO; Le Rochais M; Uguen A
Front Immunol; 2024; 15():1379154. PubMed ID: 38742102
[TBL] [Abstract][Full Text] [Related]
27. Applications of Mass Cytometry in Clinical Medicine: The Promise and Perils of Clinical CyTOF.
Behbehani GK
Clin Lab Med; 2017 Dec; 37(4):945-964. PubMed ID: 29128078
[TBL] [Abstract][Full Text] [Related]
28. Navigating the cellular landscape in tissue: Recent advances in defining the pathogenesis of human disease.
Chen HY; Palendira U; Feng CG
Comput Struct Biotechnol J; 2022; 20():5256-5263. PubMed ID: 36212528
[TBL] [Abstract][Full Text] [Related]
29. Imaging Mass Cytometry.
Chang Q; Ornatsky OI; Siddiqui I; Loboda A; Baranov VI; Hedley DW
Cytometry A; 2017 Feb; 91(2):160-169. PubMed ID: 28160444
[TBL] [Abstract][Full Text] [Related]
30. Multiple TOF/TOF Events in a Single Laser Shot for Multiplexed Lipid Identifications in MALDI Imaging Mass Spectrometry.
Prentice BM; McMillen JC; Caprioli RM
Int J Mass Spectrom; 2019 Mar; 437():30-37. PubMed ID: 30906202
[TBL] [Abstract][Full Text] [Related]
31. Three-dimensional imaging mass cytometry for highly multiplexed molecular and cellular mapping of tissues and the tumor microenvironment.
Kuett L; Catena R; Özcan A; Plüss A; ; Schraml P; Moch H; de Souza N; Bodenmiller B
Nat Cancer; 2022 Jan; 3(1):122-133. PubMed ID: 35121992
[TBL] [Abstract][Full Text] [Related]
32. Mass cytometry: a highly multiplexed single-cell technology for advancing drug development.
Atkuri KR; Stevens JC; Neubert H
Drug Metab Dispos; 2015 Feb; 43(2):227-33. PubMed ID: 25349123
[TBL] [Abstract][Full Text] [Related]
33. Metal-Labeled Aptamers as Novel Nanoprobes for Imaging Mass Cytometry Analysis.
Yu Y; Dang J; Liu X; Wang L; Li S; Zhang T; Ding X
Anal Chem; 2020 May; 92(9):6312-6320. PubMed ID: 32208602
[TBL] [Abstract][Full Text] [Related]
34. Dual electrospray ionization source for confident generation of accurate mass tags using liquid chromatography Fourier transform ion cyclotron resonance mass spectrometry.
Nepomuceno AI; Muddiman DC; Bergen HR; Craighead JR; Burke MJ; Caskey PE; Allan JA
Anal Chem; 2003 Jul; 75(14):3411-8. PubMed ID: 14570191
[TBL] [Abstract][Full Text] [Related]
35. Application of High-Throughput Imaging Mass Cytometry Hyperion in Cancer Research.
Le Rochais M; Hemon P; Pers JO; Uguen A
Front Immunol; 2022; 13():859414. PubMed ID: 35432353
[TBL] [Abstract][Full Text] [Related]
36. Single-cell high-dimensional imaging mass cytometry: one step beyond in oncology.
Glasson Y; Chépeaux LA; Dumé AS; Lafont V; Faget J; Bonnefoy N; Michaud HA
Semin Immunopathol; 2023 Jan; 45(1):17-28. PubMed ID: 36598557
[TBL] [Abstract][Full Text] [Related]
37. New-generation technologies for spatial tissue analysis, indispensable tools for deciphering intratumor heterogeneity in the development of antibody-drug conjugates and radio-immunoconjugates for cancer treatment.
Radosevic-Robin N; Kossai M; Penault-Llorca F
Transl Breast Cancer Res; 2023; 4():28. PubMed ID: 38751472
[TBL] [Abstract][Full Text] [Related]
38. Imaging Mass Cytometry in Immuno-Oncology.
Cotechini T; Jones O; Hindmarch CCT
Methods Mol Biol; 2023; 2614():1-15. PubMed ID: 36587115
[TBL] [Abstract][Full Text] [Related]
39. Highly multiplexed imaging of tumor tissues with subcellular resolution by mass cytometry.
Giesen C; Wang HA; Schapiro D; Zivanovic N; Jacobs A; Hattendorf B; Schüffler PJ; Grolimund D; Buhmann JM; Brandt S; Varga Z; Wild PJ; Günther D; Bodenmiller B
Nat Methods; 2014 Apr; 11(4):417-22. PubMed ID: 24584193
[TBL] [Abstract][Full Text] [Related]
40. CyTOF: An Emerging Technology for Single-Cell Proteomics in the Mouse.
Tracey LJ; An Y; Justice MJ
Curr Protoc; 2021 Apr; 1(4):e118. PubMed ID: 33887117
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
